In vitro oxime protection of human red blood cell acetylcholinesterase inhibited by diisopropyl-fluorophosphate

Journal of Applied Toxicology

Volumn 28, Issue 4, 2008, Pages 422-429

  Lorke, D E ^a,d   Hasan, M Y ^a   Arafat, K ^a   Kuca K ^b   Musilek, K ^b   Schmitt, A ^c   Petroianu, G A ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b UNIVERSITY OF DEFENCE   (Czech Republic)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Cholinesterase; DFP; K oximes; Organophosphate; Oxime; Schild equation

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; ACETYLCHOLINESTERASE; DYFLOS; METHOXIME; OBIDOXIME; OXIME DERIVATIVE; PRALIDOXIME; TRIMEDOXIME;

ARTICLE; BINDING AFFINITY; ENZYME ASSAY; ENZYME INHIBITION; ERYTHROCYTE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; PRIORITY JOURNAL;

ACETYLCHOLINESTERASE; ANTIDOTES; CHOLINESTERASE INHIBITORS; CHOLINESTERASE REACTIVATORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; FEMALE; HUMANS; ISOFLUROPHATE; MALE; MODELS, BIOLOGICAL; OXIMES; PROTEIN BINDING;

EID: 44149119794     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1344     Document Type: Article

References (39)

1. Alston TA. 2005. Pralidoxime rescues both muscarinic and nicotinic systems. Anesth. Analg. 101: 926-927.
2. Arunlakshana O, Schild HO. 1959. Some quantitative uses of drug antagonists. Br. J. Pharmac. Chemother. 14: 48-58.
3. Bajgar J. 2004. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv. Clin. Chem. 38: 151-216.
4. Bay E, Krops S, Yates LF. 1958. Chemotherapeutic effectiveness of 1,1′-trimethylene bis (4-formyl-pyridinium bromide) di-oxime (TMB-4) in experimental anticholinesterase poisoning. Proc. Soc. Exp. Biol. Med. 98: 107-110.
5. Brown ND, Gray RR, Stermer-Cox MG, Doctor BP, Hagedorn I. 1984. Stability study of HI-6 dichloride in various anticholinergic formulations. J. Chromatogr. 315: 389-394.
6. Buckley N, Eddleston M, Szinicz L. 2005. Oximes for acute organophosphate pesticide poisoning. Cochrane Database Syst. Rev. 1: CD005085.
7. Carrington CD, Abou Donia MB. 1985. Characterization of [3H]diisopropyl phosphorofluoridate-binding proteins in hen brain. Rates of phosphorylation and sensitivity to neurotoxic and non-neurotoxic organophosphorus compounds. Biochem. J. 228: 537-544.
8. Cheng HC. 2001. The power issue: determination of KB or Ki from IC50. A closer look at the Cheng-Prusoff equation, the Schild plot and related power equations. J. Pharmacol. Toxicol. Methods. 46: 61-71.
9. Eddleston M, Szinicz L, Eyer P, Buckley N. 2002. Oximes in acute organophosphorus pesticide poisoning: a systematic review of clinical trials. Q. J. Med. 95: 275-283.
10. Ellman GL, Courtney KD, Andres VJr, Feather-Stone RM. 1961. A new and rapid colorimetric determination of acetyl-cholinesterase activity. Biochem. Pharmac. 7: 88-95.
11. Hobbiger F, Sadler PW. 1959. Protection against lethal organophosphate poisoning by quaternary pyridine aldoximes. Br. J. Pharmac. 14: 192-201.
12. Hrabinova M, Musilek K, Jun D, Kuča K. 2006. New group of xylene linker-containing acetylcholinesterase reactivators as antidotes against the nerve agent cyclosarin. J. Enzyme Inhib. Med. Chem 21: 515-519.
13. Johnson MK, Jacobsen D, Meredith TJ, Eyer P, Heath AJ, Ligtenstein DA, Marrs TC, Szinicz L, Vale JA, Haines JA. 2000. Evaluation of antidotes for poisoning by organophosphourus pesticides. Emerg. Med. 12: 22-37.
14. Kassa J. 2002. Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J. Toxicol. Clin. Toxicol. 6: 803-816.
15. Kuča K, Bielavský J, Cabal J, Bielavska M. 2003 a. Synthesis of a potential reactivator of acetylcholinesterase -1-(4-hydroxyiminomethylpyridinium)-3-(carbamoylpyridinium)-propane dibromide. Tetrahedron. Lett. 44: 3123-3125.
16. Kuča K, Bielavský J, Cabal J, Kassa J. 2003b. Synthesis of a new reactivator of tabun-inhibited acetylcholinesterase. Bioorg. Med. Chem. Lett. 13: 3545-3547.
17. Kuča K, Cabal J, Patočka J, Kassa J. 2004. Synthesis of bisquaternary symmetric bis (2-hydroxyiminomethylpyridinium) alkane dibromides and their reactivation of cyclosarin-inhibited acetylcholinesterase. Lett. Org. Chem. 1: 84-86.
18. Kuča K, Bartosova L, Jun D, Patocka J, Cabal J, Kassa J, Kunesova G. 2005. New quaternary pyridine aldoximes as casual antidotes against nerve agents intoxications. Biomed. Pap. Med. Fac. Univ. Palacky, Olomouc. Czech. Repub. 149: 75-82.
19. Kuča, K., Jun, D., and Bajgar, J. 2007. Currently used cholinesterase reactivators against nerve agent intoxication: comparison of their effectivity in vitro. Drug Chem. Toxicol. 30: 31
20. Lange W, von Krüger G. 1932. Über Ester der Mono-Fluorphosphorsäure. Ber. Dtsch. Chem. Ges. 65: 1598-1601.
21. Luettringhaus A, Hagedorn I. 1964. Quaternary hydroxyiminomethyl- pyridinium salts. The dischloride of bis-(4-hydroxyiminomethyl-1-pyridinium- methyl)-ether (Lueh6), a new reactivator of acetylcholinesterase inhibited by organic phosphoric acid esters. Arzneimittelforschung 14: 1-5.
22. McCombie H, Saunders BC. 1946. Alkyl fluorophosphonates: preparation and physiological properties. Nature 157: 287-289.
23. McNamara BP, Koelle GB, Gilman A. 1946. The treatment of di-isopropyl fluorophosphate (DFP) poisoning in rabbits. J. Pharmac. Exp. Ther. 88: 27-33.
24. Musilek K, Kuča K, Jun D, Dohnal V, Dolezal M. 2005. Synthesis of a novel series of bispyridinium compounds bearing a xylene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase. J. Enzym. Inhib. Med. Chem. 20: 409-415.
25. Musilek K, Kuča K, Jun D, Dohnal V, Dolezal M. 2006. Synthesis of the novel series of bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase. Bioorg. Med. Chem. Lett. 16: 622-627.
26. Peter JV, Cherian AM. 2000. Organic insecticides. Anaesth. Intensive. Care. 28: 11-21.
27. Peter JV, Moran JL, Graham P. 2006. Oxime therapy and outcomes in human organophosphate poisoning: an evaluation using meta-analytic techniques. Crit. Care. Med. 34: 502-510.
28. Petroianu GA. 2005. Pralidoxime rescues both muscarinic and nicotinic systems: In response, (letter). Anesth. Analg. 101: 926-927.
29. Petroianu GA, Kalasz HJ. 2007. Comparison of the ability of oximes to reactivate human RBC cholinesterases inhibited by ethyl- and methyl-paraoxon. Curr. Org. Chem. 11: 1624-1634.
30. Petroianu GA, Missler A, Zuleger K, Thyes C, Ewald V, Maleck WH. 2004. Enzyme reactivator treatment in organophosphate exposure: the clinical relevance of thiocholine-esteratic activity of pralidoxime. J. Appl. Toxicol. 24: 429-435.
31. Petroianu GA, Arafat K, Kuča K, Kassa J. 2006a. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibited by paraoxon. J. Appl. Toxicol. 26: 64-71.
32. Petroianu GA, Nurulain SM, Nagelkerke N, Al-Sultan MA, Kuča K, Kassa J. 2006b. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: survival in rats exposed to the organophosphate paraoxon. J. Appl. Toxicol. 26: 262-268.
33. Petroianu GA, Arafat K, Nurulain SM, Kuča K, Kassa J. 2007a. In vitro oxime reactivation of red blood cell acetylcholinesterase inhibited by methyl-paraoxon. J. Appl. Toxicol. 27: 168-175.
34. Petroianu GA, Nurulain SM, Nagelkerke N, Shafiullah M, Kassa J, Kuča J. 2007b. Five oximes (K-27, K-48, obidoxime, HI-6 and trimedoxime) in comparison with pralidoxime: survival in rats exposed to methyl-paraoxon. J. Appl. Toxicol. 27: 453-457.
35. Poziomek EJ, Hackley BE, Seinberg GM. 1958. Pyridinium aldoximes. J. Org. Chem. 23: 714-717.
36. van Kampen EJ, Zijlstra WG. 1961. Standardization of hemoglobinometry II. The hemoglobincyanide method. Clin. Chim. Acta. 6: 538-544.
37. Wilson IB, Ginsburg S. 1955. A powerful reactivator of alkylphosphate inhibited acetylcholinesterase. Biochim. Biophys. Acta. 18: 168-170.
38. Worek F, Eyer P, Aurbek N, Szinicz L, Thiermann H. 2007. Recent advances in evaluation of oxime efficacy in nerve agent poisoning by in vitro analysis. Toxicol. Appl. Pharmac. 219: 226-234.
39. Worek F, Mast U, Kiderlen D, Diepold C, Eyer P. 1999. Improved determination of acetylcholinesterase activity in human whole blood. Clin. Chim. Acta 288: 73-90.